Justine Komunyena Tumusiime
ID: UNCST-2023-R008465
|
Engaging Young Women in Human-Centered Design for the Integration of HIV Prevention with Family Planning Services in Uganda
REFNo: HS2956ES
1. Understand YW’s perspectives on the pain points and opportunities related to uptake, effective use, and continuation of HIV prevention and contraceptive services.
2. Generate concepts for innovative service models for delivering voluntary contraception and HIV prevention services to YW.
3. Assess feasibility, scalability as perceived as perceived by different stakeholders, and acceptability of these models through use of prototypes and
dialogues with YW, public and private health care providers, and policymakers.
|
Uganda |
2023-07-13 10:22:52 |
2026-07-13 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Raymond Atwebembere
ID:
|
Prevalence and Factors Associated with Suicide Behavior Amongst Adolescents Living with HIV in ALow Socio-Economic Setting; Masaka District, Central Uganda
REFNo: SS1874ES
1. To assess the prevalence of Suicide Behavior Amongst Adolescents Living with HIV
2. To assess the factors associated with Suicide Behavior Amongst Adolescents Living with HIV
|
Uganda |
2023-07-13 10:15:57 |
2026-07-13 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
|
Mayanja Kajumba
ID: UNCST-2022-R009050
|
The Perspectives of Adolescents with Epilepsy: Development of a Patient-driven Intervention to Impact Health Literacy in Uganda
REFNo: HS2955ES
Aim 3: To understand key methods that the target groups use to learn, and to gather specific ideas that AWE have about effective ways to communicate information about epilepsy. That is: 3A) Identify the commonly used media and/or other epilepsy literacy delivery channels; 3B) Determine the effective ways to deliver information about epilepsy; 3C) Determine the level of accessibility to smartphones or computers, and the feasibility of using an APP or Computer Program to track seizures, and medication usage, and to deliver information about epilepsy.,Aim 2: To determine specific social groupings (e.g., school, family, community) that AWE believe most need education to impact epilepsy literacy. That is: 2A) Identify the patient’s perceived priority areas for epilepsy literacy; and 2B) Determine the patient-prioritized target social groupings for epilepsy health literacy.,Aim 1: To understand the experiences of adolescents with epilepsy (AWE) in relation to community stigma and discrimination and its impact. That is; 1A) Determine the patient history of epilepsy: the onset of seizures, and perceptions; 1B) Determine the immediate and long-term reactions/responses to epilepsy among patients, families, and community members; and 1C) Determine the nature and extent of familial, school, and community-based beliefs and misconceptions about epilepsy,The main objective of this study is to explore the relationship between epilepsy and stigma through the experiences of adolescents, who represent a pertinent target audience and are often agents of change in their communities.,
|
Uganda |
2023-07-13 10:13:23 |
2026-07-13 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Nixon Niyonzima
ID: UNCST-2020-R014577
|
A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared with Physician’s Choice of Adjuvant Endocrine Monotherapy in Patients with Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (Lidera)
REFNo: HS2193ES
Main Objective
1. To demonstrate superiority of giredestrant over the control treatment.
Specific Objectives
1. To evaluate the efficacy of giredestrant compared with Therapy of Physician's Choice
2. To evaluate the safety of giredestrant compared with Therapy of Physician's Choice
3. To characterize giredestrant Pharmacokinetics
4. To evaluate health status utility scores of participants treated with giredestrant compared with Therapy of Physician's Choice
5. To evaluate the tolerability of giredestrant compared with Therapy of Physician's Choice
6. To identify and/or evaluate biomarkers that are predictive of response to giredestrant (i.e., predictive biomarkers), are early surrogates of efficacy, are associated with progression to a more severe disease state (i.e., prognostic biomarkers), are associated with acquired resistance to giredestrant, are associated with susceptibility to developing adverse events or can lead to improved adverse event monitoring or investigation (i.e., safety biomarkers), can provide evidence of giredestrant activity (i.e., pharmacodynamic biomarkers), or can increase the knowledge and understanding of disease biology and drug safety
|
Uganda |
2023-07-13 10:07:44 |
2026-07-13 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
JOAN KABAYAMBI PROSE
ID:
|
Exploring Implementation Experiences to Adapt Digitized Payment of Community Health Workers: A Case Study of Benin and Uganda
REFNo: HS2926ES
The general objective of the study is to document the experiences of using DFS, identify good practices for the planning and implementation of gender-sensitive, national and sustainable digital health payment (DHP) of CHWs. ,iii) Design, using the identified good practices, a prototype for effective, gender-sensitive, and sustainable digital payment systems for CHWs in resource-constrained settings such as Benin and Uganda,ii) Assess the level of readiness and requirements for DHP of CHWs based on the experiences of using digital payment systems of community health workers during vaccination campaigns in Benin and Uganda,i) Understand the experiences, challenges, and opportunities of digital health payment systems for community health workers in Sub-Saharan Africa in immunization campaigns taking into account gender aspects ii) Assess the level of readiness and requirements for DHP of CHWs based on the experiences of using digital payment systems of community health workers during vaccination campaigns in Benin and Uganda iii) Design, using the identified good practices, a prototype for effective, gender-sensitive, and sustainable digital payment systems for CHWs in resource-constrained settings such as Benin and Uganda,
|
Uganda |
2023-07-11 11:25:02 |
2026-07-11 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Eddy Walakira Joshua
ID: UNCST-2022-R009077
|
Forced Labor Measurement Study: Ugandan Labor Migrants in the Middle East
REFNo: SS1872ES
Overall objective
To provide representative estimates of experiences of forced labor indicators among Ugandan migrant workers in the Middle East based on The International Conference of Labour Statisticians’ (ICLS) Guidelines concerning the measurement of forced labour, 2018.
Specific objectives
I. Explore the best way to interpret and operationalize the definitions presented in the guidelines
II. Explore how the ways in which questions are asked affects responses
III.Provide recommendations to improve questionnaire design and ultimately data quality
|
Uganda |
2023-07-11 11:22:59 |
2026-07-11 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
joseph mwizerwa
ID:
|
Promoting Cultural Humility Through a Collaborative Online Transcultural Education and Leadership Development for Nurses in the Global Community
REFNo: HS2856ES
3. Conduct a posttest (endline) survey to evaluate the success of the training intervention in improving the participants’ leadership and collaborative competencies.,2. Design and implement appropriate/customized learning activities/course content informed by the baseline survey results.,1. Carry out a pretest to understand the participants’ baseline collaborative and leadership competencies prior to the intervention.,Develop an assessment process to determine whether students (graduates and/or undergraduates) are achieving the planned global learning and leadership development outcomes.,Design learning activities and course content that will allow students to demonstrate global learning and leadership development outcomes,Initiate a course syllabus or co-curriculum revision process to define global learning and leadership development outcomes for a course or academic program for graduates and undergraduate nursing students.,
|
Uganda |
2023-07-10 17:48:52 |
2026-07-10 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Clovice Kankya
ID: UNCST-2020-R010154
|
Taxonomic Assessment of Selected Angiosperm Families in East Africa
REFNo: A318ES
Broad Objective
To provide a comprehensive study on the taxonomic and phylogenetic analysis of the Hydnoraceae, Poaceae, Viburnaceae, Velloziaceae, and Rutaceae species in East Africa.
Specific Objectives
a. To explore the inter-species diversity in Hydnoraceae from East Africa.
b. To produce the first revision of tribe Cynodonteae in the Flora of Central Africa.
c. To assess the taxonomic status of Sambucus L., (Viburnaceae) in East Africa.
d. To understand the taxonomic update and revision of the family Velloziaceae.
e. To provide a taxonomic revision of the genus Zanthoxylum and Vepris in East Africa.
|
Uganda |
2023-07-10 17:24:14 |
2026-07-10 |
Agricultural Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Arthur Mpimbaza
ID: UNCST-2022-R008866
|
Risk of contracting malaria among hospitalized patients at Jinja regional referral hospital, Uganda: a prospective cohort study.
REFNo: HS2918ES
The objective of this study is to determine the risk of hospitalized patients with non-malarial illnesses contracting malaria during their stay in hospital.
|
Uganda |
2023-07-07 11:07:23 |
2026-07-07 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Flavia Matovu Kiweewa
ID: UNCST-2021-R013337
|
A Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the GS-9883/Emtricitabine/Tenofovir Alafenamide (GS9883/F/TAF) Fixed Dose Combination (FDC) in HIV-1 Infected Adolescents and Children.
REFNo: HS2931ES
The primary objective of this study is to confirm the dose of B/F/TAF FDC in HIV-1 infected pediatric participants, to confirm the dose of B/F/TAF TOS in HIV-1 infected pediatric participants and to evaluate the safety and tolerability these medications.
|
Uganda |
2023-07-06 17:23:47 |
2026-07-06 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|